Fundamental Biology Pdf

[Jenni Israelsen]

Inplants, we primarily draw upon the genetic and genomic resources for the model plant Arabidopsis to investigate fundamental processes such as development of leaves, flowers, fruit and seeds. We have key focus on plant hormones and the essential role they play in controlling plant growth, development and tropisms, particularly in roots. We have strong programmes of research in the molecular mechanisms that underpin plant nutrient acquisition from soil and plant response to environmental stress.

In animals, our focus is on reproduction and development in livestock. Research spans from endocrine studies that investigate mechanisms regulating oestrous cycle and ovary function to molecular studies that elucidate mechanisms controlling early embryo development and stem cells differentiation and tissue programming. Our findings in animal models, such as pig, are being used to better understand human development and disease.

Facility for the characterisation of the sizes, shapes and interactions of large macro molecules of biomedical and industrial importance in the environment that many occur naturally - water or aqueous solution.

Studying the mechanisms that regulate the development of early embryos to develop novel strategies for the derivation of stem cells from germ cells and to reprogram cells towards muscle and germ cell progenitors.

Fundamentals of Biology focuses on the basic principles of biochemistry, molecular biology, genetics, and recombinant DNA. These principles are necessary to understanding the basic mechanisms of life and anchor the biological knowledge that is required to understand many of the challenges in everyday life, from human health and disease to loss of biodiversity and environmental quality.

The site is secure.

The ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Exosomes are nanosized membrane particles that are secreted by cells that transmit information from cell to cell. The information within exosomes prominently includes their protein and RNA payloads. Exosomal microRNAs in particular can potently and fundamentally alter the transcriptome of recipient cells. Here we summarize what is known about exosome biogenesis, content, and transmission, with a focus on cardiovascular physiology and pathophysiology. We also highlight some of the questions currently under active investigation regarding these extracellular membrane vesicles and their potential in diagnostic and therapeutic applications.

A major research focus across the CRUK Cambridge Centre is furthering our understanding of the molecular and cellular changes which transform normal healthy cells into cancer cells, and which co-opt other cells in the body to support cancer growth and spread. Researchers and clinicians across the Programme work together to apply scientific discoveries to the clinic, from finding new ways of detecting cancer as early as possible to developing treatments to stop tumours from growing and spreading.

Our Programme represents a team of over 200 laboratory researchers, based across 36 departments, institutes and organisations within Cambridge, who perform fundamental biological research at the very cutting edge of discovery. We encompass research groups who seek to understand the fundamental biology of cancer cells, how developmental processes influence this biology, and how cancer cells co-opt other cells in the body to support cancer growth and spread. Our work includes studies using model systems, such as flies, yeast, mice, and human cancer cells and tissues, as part of their research. Members of the Programme additionally use next-generation sequencing of DNA and RNA, mass spectrometry, cellular imaging, immune and stromal profiling, and structural studies to understand the building blocks of life.

Our collaborative aim across the Programme is to forward-translate novel fundamental biological research towards the development and refinement of cancer diagnostics and treatments, whilst concurrently reverse-translating insights from clinical trials back to basic research laboratories to assist with development of better anti-cancer therapies. In doing so, we are expanding the expertise and infrastructure within leading-edge basic cancer research.

They discuss plant biology research aiming to combat food insecurity by creating heartier and more diverse feed crops, new research approaches that enable scientists to sustainably synthesize therapeutic compounds from plants, and to pinpoint (and replicate) the genetic drivers of certain plants' ability to thrive in difficult climates, and an exciting new strategy for carbon-sequestration. Watch the talk below:

Whitehead Institute Member Sebastian Lourido and colleagues performed the first genome-wide screen of Toxoplasma gondii in live hosts, uncovering genes that are important for infection but had been undetected in cell culture experiments. Their results demonstrate the importance of studying parasites in live hosts and point to a possible new drug target.

technology under the jurisdiction of another agency, printed books, publicly available technology, technology that has been or will be published, technology that arises during or results from fundamental research, educational technology, and technology in certain patent applications (Part 734.3)

Research in the United States would be subject to the EAR unless it met one of the exclusions noted above. Much of the research in University laboratories is not subject to the EAR if it is fundamental research.

Fundamental research means research in science, engineering, or mathematics, the results of which ordinarily are published and shared broadly within the research community, and for which the researchers have not accepted restrictions for proprietary or national security reasons.

It is not considered fundamental research when there are restrictions placed on the outcome of the research or restrictions on methods used during the research. Proprietary research, industrial development, design, production, and product utilization the results of which are restricted and government funded research that specifically restricts the outcome for national security reasons are not considered fundamental research.

- Example: A university has a collaborative research agreement with a private company. The company releases its proprietary technology to the university to conduct the research with the condition that it not be released to the public. The university agrees to a non-disclosure statement as part of the collaborative agreement. The company proprietary information, if subject to the Export Administration Regulations (i.e., not subject to the jurisdiction of another Agency, e.g., the Department of State and the International Trade in Arms Regulation), may require deemed export licensing authorization if released to a foreign national.

If your research is NOT fundamental Research, then your technology may be subject to the EAR, but does it require a license ? Does your biological research involve a controlled pathogen (1C351, 1C353, 1C354, 1C991) or controlled equipment (2B352)? Please review the Commerce Control List which can be found at www.bis.doc.gov.

If you are working with controlled pathogens or equipment, then the technology being shared with the foreign national needs to be determined. There are 5 main technology ECCNs that need to be reviewed for biological research:

The field of biotherapy regroups the therapeutics based on the use of molecules designed from a living organism. Biotherapies comprise cell and tissue therapy, gene therapy and therapies using human molecules synthesized by eukaryotic cells or bacteria, as antibodies and bioactive proteins.

This domain has considerably evolved during the recent years thanks to the research progress in vectorology, stem cells, biomaterials, omics and computational biology, which have transformed the practices of research laboratories in fundamental biology and biotherapy and allowed numerous clinical trials to emerge. The societal and ethical impact of these new features is huge and the area of biotherapy will need experts in the next future. Future researchers in this field require a strong education in the molecular basis of the physiopathological processes to develop new biotherapy strategies.

You have to apply through the eCandidat platform, that will be available from March 28th to June 13th. You must submit your application before May 15th, 2024. After this date, the application committee will review submitted applications and the program may already be full.

You will need to upload supporting documents:

2. A one page Curriculum Vitae

3. An English language certificate (TOEIC, TOEFL, Cambridge, or certificate of English as medium of instruction)

4. Transcripts and diplomas of higher education

5. Two letters of recommendation

- Once you have applied via one of these two platforms, please fill in this form to complete your information. Especially, you will need to indicate your choice of option for the second semester, and your application for a student residence.

Genes and molecules in Development: 6 ECTS

Stem cell biology and technology: 6 ECTS

Evolution and development: 6 ECTS

Developmental and Comparative neurobiology: 3 ECTS

Evolution and Development of the immune system: 3 ECTS

Our international masters programme From fundamental molecular biosciences to biotherapies is here to offer our students an accute and complete professional training in the field, which is why we encourage our students to complete an internship abroad, in one of the following laboratories from our partner universities:

Students registered at Sorbonne Universit will follow the 1st semester of the M1 year in Paris, move for the 2nd semester to one partner university depending on the option chosen and come back to Paris for the M2 year, except for the option Fundamental molecular biosciences in biotherapies in which students will move during the 2nd semester of the M2 year.

3a8082e126